We are live on ! Find out more
LA

Linden Advisors Portfolio holdings

AUM $17.9B
1-Year Est. Return 1.72%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+1.72%
3 Year Est. Return
+2.79%
5 Year Est. Return
+3.4%
10 Year Est. Return
+25.58%
AUM
$9.53B
AUM Growth
-$1.41B
Cap. Flow
-$9.67B
Cap. Flow %
-101.51%
Top 10 Hldgs %
31.88%
Holding
730
New
16
Increased
Reduced
3
Closed
155
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASBPW
276
Aspire Biopharma Warrant
ASBPW
$579K
$36.6K ﹤0.01%
899,999
JUN.WS
277
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
$36.5K ﹤0.01%
244,899
TGVCW
278
DELISTED
TG Venture Acquisition Corp. Warrants
TGVCW
$36.4K ﹤0.01%
600,000
FGMCW
279
DELISTED
FG Merger Corp. Warrant
FGMCW
$36.1K ﹤0.01%
412,499
GFX.WS
280
DELISTED
Golden Falcon Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
GFX.WS
$35.8K ﹤0.01%
230,875
LFLY
281
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$35.2K ﹤0.01%
3,000
RFACR
282
DELISTED
RF Acquisition Corp. Rights
RFACR
$34.7K ﹤0.01%
375,000
CLRCR
283
DELISTED
ClimateRock Right
CLRCR
$34.5K ﹤0.01%
300,000
SPCMW
284
DELISTED
Sound Point Acquisition Corp I, Ltd Warrant
SPCMW
$34.4K ﹤0.01%
299,999
KSICW
285
DELISTED
Kadem Sustainable Impact Corporation Warrant
KSICW
$32.6K ﹤0.01%
811,806
SVNAW
286
DELISTED
7 Acquisition Corp Warrant
SVNAW
$32K ﹤0.01%
249,999
ENERR
287
DELISTED
Accretion Acquisition Corp Right
ENERR
$31.8K ﹤0.01%
400,000
ABVEW
288
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$31.6K ﹤0.01%
466,193
PUCKW
289
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$31.2K ﹤0.01%
641,916
XBPEW
290
XBP Europe Holdings Warrant
XBPEW
$29.7K ﹤0.01%
1,040,133
VMCAW
291
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
$29.1K ﹤0.01%
375,000
HMA.WS
292
DELISTED
Heartland Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
HMA.WS
$28.5K ﹤0.01%
727,170
APN.WS
293
DELISTED
Apeiron Capital Investment Corp. Redeemable Warrants
APN.WS
$25.5K ﹤0.01%
299,999
ROSEW
294
DELISTED
Rose Hill Acquisition Corporation Warrant
ROSEW
$25.3K ﹤0.01%
199,999
PRSTW
295
DELISTED
Presto Technologies, Inc. Warrant
PRSTW
$25.2K ﹤0.01%
547,327
ORIAW
296
DELISTED
Orion Biotech Opportunities Corp. Warrant
ORIAW
$24.9K ﹤0.01%
139,998
BNZIW icon
297
Banzai International Warrant
BNZIW
$126K
$24.1K ﹤0.01%
335,465
CPAAW
298
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
$24K ﹤0.01%
135,197
BIOSW
299
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$23K ﹤0.01%
500,000
MLACW
300
DELISTED
Malacca Straits Acquisition Company Limited Warrants
MLACW
$22K ﹤0.01%
489,600

Similar funds

Linden Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Linden Advisors held 730 positions worth $9.53B, down 13% from $10.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Linden Advisors withdrew a net $9.67B in Q4 2022, closing 155 positions and reducing 3 holdings. Its most notable exit was Angel Pond Holdings Corporation, an estimated $24M position sold in full.

By sector, the portfolio is most concentrated in Financials at 7.8% of assets, down from 10% a quarter earlier, followed by Technology and Industrials.

Against the trend, Linden Advisors opened a new position in Axon Enterprise worth $16M.

  • Linden Advisors's largest Q4 2022 buy was Axon Enterprise: 96,539 shares worth $16M.
  • Linden Advisors's biggest Q4 2022 reduction was Everest Consolidator Acquisition Corporation, cutting an estimated $3.79M.
  • Linden Advisors fully exited Angel Pond Holdings Corporation in Q4 2022, selling an estimated $24M.
  • Linden Advisors's ten largest holdings make up 32% of its $9.53B portfolio in Q4 2022.
  • Linden Advisors opened 16 new positions and closed 155 in Q4 2022.
  • Linden Advisors's portfolio value fell 13% quarter-over-quarter to $9.53B.

Based on Linden Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.